Disease · MONDO_0005416
Comparisons in its trials36
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 36
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Ampion 4 mL Dose vs Placebo 4 mL Dose: deaths from any cause | 1 of 520 | 0 of 523 | 1,043 | NCT03988023 | Trial comparisons |
| Ampion 4 mL Dose vs Placebo 4 mL Dose: serious adverse events | 16 of 520 | 11 of 523 | 1,043 | NCT03988023 | Trial comparisons |
| SMC021 Oral Calcitonin vs SMC021 Placebo: serious adverse events | 77 of 520 | 80 of 508 | 1,028 | NCT00704847 | Trial comparisons |
| 4 mL AMPION™ vs 4 mL Saline Placebo: deaths from any cause | 0 of 236 | 0 of 243 | 479 | NCT02556710 | Trial comparisons |
| 4 mL AMPION™ vs 4 mL Saline Placebo: serious adverse events | 2 of 236 | 4 of 243 | 479 | NCT02556710 | Trial comparisons |
| Tramadol HCl Contramid® Once A Day vs Tramadol HCl Twice a Day (SR): serious adverse events | 3 of 215 | 8 of 215 | 430 | NCT00950651 | Trial comparisons |
| Semaglutide 2.4 mg vs Placebo: deaths from any cause | 0 of 269 | 0 of 135 | 404 | NCT05064735 | Trial comparisons |
| Semaglutide 2.4 mg vs Placebo: serious adverse events | 27 of 269 | 11 of 135 | 404 | NCT05064735 | Trial comparisons |
| Diacerein vs Celecoxib: deaths from any cause | 0 of 186 | 0 of 190 | 376 | NCT02688400 | Trial comparisons |
| Diacerein vs Celecoxib: serious adverse events | 3 of 186 | 4 of 190 | 376 | NCT02688400 | Trial comparisons |
| Diacerein vs Celecoxib: OARSI Responders | 99 of 183 | 97 of 187 | 370 | NCT02688400 | Trial comparisons |
| Meloxicam vs Placebo: deaths from any cause | 0 of 184 | 0 of 180 | 364 | NCT01799213 | Trial comparisons |
| Meloxicam vs Placebo: serious adverse events | 4 of 184 | 3 of 180 | 364 | NCT01799213 | Trial comparisons |
| Ampion 4 mL vs Placebo 4 mL: deaths from any cause | 0 of 172 | 1 of 170 | 342 | NCT02242435 | Trial comparisons |
| Ampion 4 mL vs Placebo 4 mL: serious adverse events | 4 of 172 | 11 of 170 | 342 | NCT02242435 | Trial comparisons |
| EP-104IAR 25 mg vs Placebo (Vehicle): Difference Between EP-104IAR and Vehicle in OMERACT-OARSI Strict Responders | 87 of 163 | 61 of 155 | 318 | NCT04120402 | Trial comparisons |
| EP-104IAR 25 mg vs Placebo (Vehicle): deaths from any cause | 0 of 163 | 0 of 155 | 318 | NCT04120402 | Trial comparisons |
| EP-104IAR 25 mg vs Placebo (Vehicle): serious adverse events | 4 of 163 | 1 of 155 | 318 | NCT04120402 | Trial comparisons |
| Diclofenac Diethylamine, DDEA 2.32% Gel vs Placebo: serious adverse events | 0 of 153 | 0 of 151 | 304 | NCT01967550 | Trial comparisons |
| Flavocoxid 500 mg vs Naproxen 500 mg: deaths from any cause | 0 of 108 | 0 of 115 | 223 | NCT00790985 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005416/comparisons